Literature DB >> 21038085

Reversible gastric restriction implant: safety and efficacy in a canine model.

Xiaomei Guo1, Hai Zheng, Samer G Mattar, Xiao Lu, George Sandusky, Jose A Navia, Ghassan Kassab.   

Abstract

BACKGROUND: Gastric restrictive procedures are considered effective weight loss treatment for severe obesity. The aim of the study was to evaluate the efficacy and safety of a reversible implant that renders a partial restriction of stomach in a canine model.
METHODS: The device was comprised of two longitudinal parallel non-compressive plates with two C-rings to create a small gastric pouch that opposed gastric distension. Three groups of non-obese mongrel dogs were included: group I (n = 6) underwent surgical implant for 6 weeks, group II (n = 6) underwent surgical implant for 6 weeks, followed by surgical removal of the implant and additional monitoring for 5 weeks, and group III (n = 5) served as sham-operated controls for groups I and II. Food intake and body weight were monitored, and the stomachs were examined histologically postmortem.
RESULTS: The average food intake was significantly decreased by 38.2% in group I as compared to group III throughout the 6 weeks of surgical implant (P < 0.05). The implanted dogs showed a progressive weight loss as compared to sham, which reached 21% by the end of 6 weeks. In group II, after 5 weeks of implant removal, the body weights recovered to approximately 96% of baseline. Histological evidence of the implant site at the gastric walls revealed no significant structural changes, tissue ischemia, hemorrhage, or necrosis.
CONCLUSION: Our results validate the feasibility of a reversible gastric restriction implant in a non-obese canine model, with the potential for achieving significant weight loss within 6 weeks and with no injury to the gastric wall.

Entities:  

Mesh:

Year:  2011        PMID: 21038085     DOI: 10.1007/s11695-010-0299-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  30 in total

1.  Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.

Authors:  Susumu Suzuki; Eduardo J B Ramos; Carolina G Goncalves; Chung Chen; Michael M Meguid
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Ghrelin levels and sleeve gastrectomy in super-super-obesity.

Authors:  Régis Cohen; Bernard Uzzan; Hélène Bihan; Inès Khochtali; Gérard Reach; Jean Marc Catheline
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

Review 3.  Diets, drugs, exercise, and behavioral modification: Where these work and where they do not.

Authors:  Robert Kushner
Journal:  Surg Obes Relat Dis       Date:  2005 Mar-Apr       Impact factor: 4.734

4.  Morbid obesity: use of vertical banded gastroplasty.

Authors:  E E Mason
Journal:  Surg Clin North Am       Date:  1987-06       Impact factor: 2.741

5.  Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.

Authors:  Gianfranco Silecchia; Cristian Boru; Alessandro Pecchia; Mario Rizzello; Giovanni Casella; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

6.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Trends in obesity and energy supply in the WHO MONICA Project.

Authors:  K Silventoinen; S Sans; H Tolonen; D Monterde; K Kuulasmaa; H Kesteloot; J Tuomilehto
Journal:  Int J Obes Relat Metab Disord       Date:  2004-05

8.  Results of the surgical treatment of obesity.

Authors:  L D MacLean; B M Rhode; J Sampalis; R A Forse
Journal:  Am J Surg       Date:  1993-01       Impact factor: 2.565

9.  Can morbidly obese patients safely lose weight preoperatively?

Authors:  L F Martin; T L Tan; P A Holmes; D A Becker; J Horn; E O Bixler
Journal:  Am J Surg       Date:  1995-02       Impact factor: 2.565

10.  Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study.

Authors:  M Goergen; K Arapis; A Limgba; M Schiltz; V Lens; J S Azagra
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

View more
  1 in total

1.  Efficacy of a laparoscopic gastric restrictive device in an obese canine model.

Authors:  Xiaomei Guo; Samer G Mattar; Scott E Mimms; Jose A Navia; Ghassan S Kassab
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.